Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'signaling pathways cell cycle checkpoint aurora kinase vx 680 mk 0457 tozasertib'

Search results for: 'signaling pathways cell cycle checkpoint aurora kinase vx 680 mk 0457 tozasertib'

Items 1-10 of 1350

Page
per page
  1. MK 6096
    A8953 MK 6096
    Summary: OX1/OX2 receptor antagonist
      Soluble in DMSO
  2. MLN8237 (Alisertib)
    A4110 MLN8237 (Alisertib)
     10 Citation
    Summary: Aurora A Kinase inhibitor, Potent and selective
      ≥25.95 mg/mL
  3. (+)-MK 801
    A3100 (+)-MK 801
    Target: NMDA Receptors
    Summary: Potent NMDA antagonist
      insoluble in H2O; ≥10.45 mg/mL
  4. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: Glucagon receptor/IGF-1R antagonist
      ≥24.05 mg/mL
  5. MK 0343
    B5585 MK 0343
    Summary: GABAA partial agonist
      <39.74 mg/mL
  6. MK 1903
    B5658 MK 1903
    Summary: hydroxycarboxylic acid receptor 2 (HCA2, GPR109A) full agonist
      <16.42 mg/mL
  7. MK 886
    B6684 MK 886
     1 Citation
    Summary: A FLAP and PPARα inhibitor, capable of inhibiting leukotriene biosynthesis and inducing apoptosis
      ≥15.1 mg/mL
  8. (-)-MK 801
    B1627 (-)-MK 801
    Target: NMDA Receptors
    Summary: NMDA antagonist,potent and selective
      insoluble in H2O; ≥10.3 mg/mL
  9. DiscoveryProbe™ Cell Cycle Library
    L1037 DiscoveryProbe™ Cell Cycle Library
    Summary: A unique collection of 449 cell cycle-related compounds for cell cycle research.
  10. (+)-MK 801 Maleate
    A8896 (+)-MK 801 Maleate
    Summary: Potent NMDA antagonist
      ≥16.85 mg/mL

Items 1-10 of 1350

Page
per page